[Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
OBJECTIVE
Long-term therapy of haematology patients has been facilitated by permanent indwelling central venous catheters. We performed a retrospective study to compare the problems occurring with a externalized catheter (Hickman) versus a totally implanted port catheter.


METHODS
A total of 171 catheters were placed to 139 haematological patients, 77 patients with Hickman catheters and 94 with totally implanted port catheters. We review our experience in order to identify factors associated with complications.


RESULTS
Pneumothorax occurred in one of 171 of the percutaneously placed devices. Other early complications were hematoma 13, and catheter migration out of the vascular tree 8. Late complications included malposition (5.8%), thrombosis (2.9%), septic thrombosis (1.7%) and most notably infection (38.5%). 62 of 77 patients with Hickman catheters developed catheter-related infection (hazard rate infection 7.1/1000 days) compared with 53 of 94 patients with implanted port catheters (hazard rate infection 1.5/1000 days, p < 0.001). Most of infections that occurred were caused by gram-positive organisms but the gram-negative organisms infections resulted in a significantly higher rate of treatment failure and recurrence. A total of 72 catheters were removed of the central line: 36 for infection.


CONCLUSIONS
We found a significantly increased incidence of catheter-related infection in patients with Hickman catheters. We also observed that the use of intravenous antibiotic prophylaxis prior to catheter insertion did not appear to be beneficial and thrombocytopenia at this moment was a factor in the development of hematoma. The infections due to coagulase-positive staphylococci can be treated successfully without removal of the catheters. However in catheter-related bacteremia due gram-negative organisms there is a chance that the bacteremia will recur if the catheter is not removed.
Albo López
C
C
Servicio de Hematología, Radiología Intervencionista, Hospital Xeral-Cies, Vigo. calbo@.unicies.cesga.es
López Rodríguez
D
D
Constenla Camba
M I
MI
Jimenéz Blanco
A
A
Araujo
L F
LF
García-Medina
J
J
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016470:Bacteremia / Q000453:epidemiology / Q000209:etiology*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004866:Equipment Contamination; D005260:Female; D005548:Foreign-Body Migration / Q000453:epidemiology / Q000209:etiology; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D019337:Hematologic Neoplasms / Q000150:complications* / Q000628:therapy; D006406:Hematoma / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011030:Pneumothorax / Q000209:etiology; D011292:Premedication; D012189:Retrospective Studies; D013030:Spain / Q000453:epidemiology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D013921:Thrombocytopenia / Q000150:complications; D020246:Venous Thrombosis / Q000209:etiology*
D000900:Anti-Bacterial Agents